Xin‐Ran Tang

531 total citations
24 papers, 325 citations indexed

About

Xin‐Ran Tang is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xin‐Ran Tang has authored 24 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 9 papers in Surgery and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xin‐Ran Tang's work include Vascular Procedures and Complications (5 papers), Coronary Interventions and Diagnostics (5 papers) and Acute Myocardial Infarction Research (5 papers). Xin‐Ran Tang is often cited by papers focused on Vascular Procedures and Complications (5 papers), Coronary Interventions and Diagnostics (5 papers) and Acute Myocardial Infarction Research (5 papers). Xin‐Ran Tang collaborates with scholars based in China, United States and Italy. Xin‐Ran Tang's co-authors include Ying Xian, Xinjian Chen, Baoqing Nie, Yang Wang, Marc S. Sabatine, Xuan Jia, Wei Li, Wei Zhao, Yuejin Yang and Jingang Yang and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Xin‐Ran Tang

22 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xin‐Ran Tang China 8 115 72 71 64 34 24 325
Shuai Jin China 9 70 0.6× 36 0.5× 67 0.9× 85 1.3× 18 0.5× 29 303
Xiaolan Chen China 9 54 0.5× 57 0.8× 30 0.4× 45 0.7× 18 0.5× 20 232
Ammar Ismail Egypt 11 112 1.0× 99 1.4× 54 0.8× 47 0.7× 20 0.6× 23 379
Markus Vosseler Germany 8 122 1.1× 82 1.1× 62 0.9× 25 0.4× 24 0.7× 25 345
Karen Nelson Germany 11 115 1.0× 88 1.2× 184 2.6× 11 0.2× 13 0.4× 20 310
Zhichao Sun China 13 61 0.5× 92 1.3× 33 0.5× 34 0.5× 38 1.1× 37 388
Y. Schwartz Israel 10 88 0.8× 64 0.9× 44 0.6× 22 0.3× 35 1.0× 29 314
W. Y. Sun China 10 65 0.6× 81 1.1× 18 0.3× 40 0.6× 13 0.4× 19 212
Mingjun Xu China 9 143 1.2× 48 0.7× 61 0.9× 15 0.2× 53 1.6× 38 240
Rafael Y. Brzezinski Israel 10 159 1.4× 54 0.8× 51 0.7× 17 0.3× 52 1.5× 29 377

Countries citing papers authored by Xin‐Ran Tang

Since Specialization
Citations

This map shows the geographic impact of Xin‐Ran Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin‐Ran Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin‐Ran Tang more than expected).

Fields of papers citing papers by Xin‐Ran Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin‐Ran Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin‐Ran Tang. The network helps show where Xin‐Ran Tang may publish in the future.

Co-authorship network of co-authors of Xin‐Ran Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Xin‐Ran Tang. A scholar is included among the top collaborators of Xin‐Ran Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin‐Ran Tang. Xin‐Ran Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Xin‐Ran, Lijuan Liu, Yayun Wu, et al.. (2024). An inulin-type polysaccharide from Atractylodis Macrocephalae Rhizoma can relieve psoriasis. International Journal of Biological Macromolecules. 280(Pt 1). 135667–135667. 6 indexed citations
2.
Zhang, Huiling, Xin‐Ran Tang, Mengge Zhang, et al.. (2024). Geniposide ameliorates psoriatic skin inflammation by inhibiting the TLR4/MyD88/NF-κB p65 signaling pathway and MMP9. International Immunopharmacology. 133. 112082–112082. 15 indexed citations
3.
Song, Ying, et al.. (2024). The Preventive and Therapeutic Effects of Acute and Severe Inflammatory Disorders with Heparin and Heparinoid. Biomolecules. 14(9). 1078–1078. 4 indexed citations
4.
Gao, Sizhi Paul, Xin‐Ran Tang, Hikmat Al‐Ahmadie, et al.. (2023). Abstract 330: EP300 loss drives tumorigenesis in bladder cancer via activation of IL-6/JAK/STAT3 signaling. Cancer Research. 83(7_Supplement). 330–330.
5.
Cai, Qiang, et al.. (2022). Huangjia Ruangan Granule Inhibits Inflammation in a Rat Model with Liver Fibrosis by Regulating TNF/MAPK and NF-κB Signaling Pathways. Evidence-based Complementary and Alternative Medicine. 2022. 1–16. 6 indexed citations
6.
7.
Wang, Yaqin, Yu‐Pei Chen, Yu Zhang, et al.. (2018). Prognostic significance of tumor‐infiltrating lymphocytes in nondisseminated nasopharyngeal carcinoma: A large‐scale cohort study. International Journal of Cancer. 142(12). 2558–2566. 72 indexed citations
8.
Zheng, Wen, Yu‐Li Liu, Haibao Shang, et al.. (2018). Characterization of spontaneously-developed non-alcoholic fatty liver disease in aged rhesus monkeys. Diabetology & Metabolic Syndrome. 10(1). 68–68. 7 indexed citations
9.
Wang, Lijuan, Xiangyang Qian, Mingya Wang, Xin‐Ran Tang, & Hushan Ao. (2018). Which factor is the most effective one in metabolic Sydrome on the outcomes after coronary artery bypass graft surgery? A cohort study of 5 Years. Journal of Cardiothoracic Surgery. 13(1). 1–1. 5 indexed citations
10.
Jin, Chen, Wei Li, Yang Wang, et al.. (2016). Costs and Benefits Associated With Transradial Versus Transfemoral Percutaneous Coronary Intervention in China. Journal of the American Heart Association. 5(4). 28 indexed citations
11.
Chen, Yanyan, Jinping Wang, Yali An, et al.. (2015). [Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study].. PubMed. 54(1). 13–7. 6 indexed citations
12.
Xu, Haiyan, Wei Li, Jingang Yang, et al.. (2015). The China Acute Myocardial Infarction (CAMI) Registry: A national long-term registry-research-education integrated platform for exploring acute myocardial infarction in China. American Heart Journal. 175. 193–201.e3. 91 indexed citations
13.
Ao, Hushan, Fei Xu, Xianqiang Wang, et al.. (2015). Effects of Metabolic Syndrome with or without Obesity on Outcomes after Coronary Artery Bypass Graft. A Cohort and 5-Year Study. PLoS ONE. 10(2). e0117671–e0117671. 10 indexed citations
14.
Yang, Yuejin, Bo Xu, Min Yao, et al.. (2015). A Comparison of the Transradial and Transfemoral Approaches for the Angiography and Intervention in Patients with a History of Coronary Artery Bypass Surgery. Chinese Medical Journal. 128(6). 762–767. 7 indexed citations
15.
Yang, Yuejin, Bo Xu, Min Yao, et al.. (2015). Comparison of Short- and Medium-Term Clinical Outcomes between Transradial Approach and Transfemoral Approach in a High-Volume PCI Heart Center in China. PLoS ONE. 10(3). e0118491–e0118491. 3 indexed citations
16.
17.
Tang, Xin‐Ran, Jingang Yang, Wei Li, et al.. (2013). URBAN AND RURAL DIFFERENCES OF BLOOD PRESSURE AND HYPERTENSION CONTROL IN CHINESE COMMUNITIES: PURE CHINA STUDY. Journal of the American College of Cardiology. 61(10). E1350–E1350. 1 indexed citations
18.
Yang, Jingang, et al.. (2013). The Association between Atherosclerotic Renal Artery Stenosis and Acute Kidney Injury in Patients Undergoing Cardiac Surgery. PLoS ONE. 8(5). e64104–e64104. 5 indexed citations
19.
20.
Zhang, Yuqing, Xuezhong Zhang, Lisheng Liu, et al.. (2012). 381 HIGHER CARDIOVASCULAR RISK AND IMPAIRED BENEFIT OF ANTIHYPERTENSIVE TREATMENT IN HYPERTENSIVE PATIENTS REQUIRING ADDITIONAL DRUGS ON TOP OF RANDOMIZED THERAPY. IS ADDING DRUGS ALWAYS BENEFICIAL?. Journal of Hypertension. 30(Supplement 1). e112–e112. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuai Jin Breakdown of academic impact, for papers by Xiaolan Chen Breakdown of academic impact, for papers by Ammar Ismail Breakdown of academic impact, for papers by Markus Vosseler Breakdown of academic impact, for papers by Karen Nelson Breakdown of academic impact, for papers by Zhichao Sun Breakdown of academic impact, for papers by Y. Schwartz Breakdown of academic impact, for papers by W. Y. Sun Breakdown of academic impact, for papers by Mingjun Xu Breakdown of academic impact, for papers by Rafael Y. Brzezinski
Rankless by CCL
2026